Lawrence M. Sung

Patent Watch: Cephalon, Inc. v. Watson Pharms., Inc.

On February 14, 2013, in, the U.S. Court of Appeals for the Federal Circuit (Reyna, Bryson, Wallach*) reversed-in-part and affirmed-in-part the district court's judgment following a bench trial that Watson did not infringe...more

2/20/2013 - Appeals Burden of Proof Cephalon Enablement Inquiries Evidence Infringement Patents Reversal Undue Experimentation Watson Pharmaceuticals